Khare Milind D, Bukhari Sayed S, Swann Andrew, Spiers Paul, McLaren Iain, Myers Jenny
Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester LE1 5WW, UK.
J Infect. 2007 Feb;54(2):146-50. doi: 10.1016/j.jinf.2006.03.002. Epub 2006 May 5.
Central vascular catheters (CVC) are used extensively in critical care for monitoring and therapy. They can become colonised with viable micro-organisms within 24 h of insertion, which can rapidly form biofilm. This colonisation is a precursor of catheter-related bloodstream infections (CR-BSI), which are associated with substantial morbidity, mortality, prolonged hospital stay and increased cost. Antimicrobials have been incorporated into the bulk material of CVC or applied to their surfaces as a coating in an attempt to reduce the incidence of CVC colonisation and infection. This study examines the effect of a silver zeolite-impregnated catheter on catheter-related colonisation and infection in adult critical care patients. The study was conducted in adult Intensive Care Units (ICU) at three acute hospitals over 14 months and involved 246 CVC insertions (122 silver-impregnated and 124 non-impregnated). CVC tip colonisation was detected by the Maki Roll culture and CR-BSI by differential time-to-positivity of blood cultures. Overall colonisation rate was significantly lower in the silver zeolite-impregnated CVC tips (58%) as compared with the control CVC tips (73%) (p<0.025). In addition, there was a lower rate (34%) of tip colonisation by coagulase negative staphylococci in the silver zeolite-impregnated CVC tips as compared with the control CVC tips (47%) (p<0.05). Four episodes of CR-BSI were detected in each arm by differential time-to-positivity in a subset of patients. This study indicates that the silver zeolite-impregnated catheter is superior to non-impregnated catheter in reducing the rate of CVC colonisation but it showed no difference in the rates of CR-BSI in the two arms. Larger prospective randomised control studies are required to evaluate its role in the prevention of CR-BSI.
中心静脉导管(CVC)在重症监护中广泛用于监测和治疗。在插入后的24小时内,它们可能会被活的微生物定植,这些微生物可迅速形成生物膜。这种定植是导管相关血流感染(CR-BSI)的先兆,而CR-BSI与严重的发病率、死亡率、住院时间延长及费用增加相关。抗菌药物已被纳入CVC的主体材料中,或作为涂层应用于其表面,以试图降低CVC定植和感染的发生率。本研究探讨了含银沸石导管对成年重症监护患者导管相关定植和感染的影响。该研究在三家急症医院的成人重症监护病房(ICU)进行,为期14个月,涉及246次CVC插入(122次为含银导管,124次为不含银导管)。通过Maki滚动培养检测CVC尖端定植情况,通过血培养的差异阳性时间检测CR-BSI。与对照CVC尖端(73%)相比,含银沸石的CVC尖端总体定植率显著较低(58%)(p<0.025)。此外,与对照CVC尖端(47%)相比,含银沸石的CVC尖端凝固酶阴性葡萄球菌的尖端定植率较低(34%)(p<0.05)。通过对部分患者的差异阳性时间检测,每组均检测到4例CR-BSI。本研究表明,含银沸石导管在降低CVC定植率方面优于不含银导管,但在两组的CR-BSI发生率上没有差异。需要进行更大规模的前瞻性随机对照研究来评估其在预防CR-BSI中的作用。